Leuven, BELGIUM - November 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency ...

Financial information for the first nine months of 2024 Retailer revenues up 1.5% Sale of eight garden centres operated by ...

Paris, 14 November 2024 - Net Asset Value per share stood at €35.58 as of 30 September 2024, after a dividend payment of €1.08 per share on 24 May. Including the dividend, NAV per share was up 2.9% ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...